Richard Adam Norwitt

Richard Adam Norwitt (then-CEO) sells 130,775 shares at avg $143.06 for $18.7M; holds 2,786,567 derivative shares

Richard Adam Norwitt, who was President & CEO at the time, executed 3 separate sales totaling 130,775 shares for $18,709,065.94 between May 1–5, 2026, at prices ranging from $142.04 to $143.90 versus a current price of $153.80. His non-derivative holdings fell 6.4% from 2,058,282 to 1,927,507 shares post-transaction, while derivative holdings (stock options across three accounts) total 2,786,567 shares, representing his substantial long-term position in the company. Across his prior open-market sales history, his 90-day well-timed rate is 62.50%, and at this same ticker, 4 of 5 prior sells generated negative 90-day returns—a pattern suggesting historical precision in exits. This month's sales occurred during a 30-day run of +23.4% appreciation and within 7.9% of the 52-week high of $167.04, creating context for evaluation of the timing and intent of the transactions.

Amphenol CEO Richard Adam sold 608,333 shares for $89,577,563.33 on 2026-02-12, reducing holdings by -41.3%

CEO Richard Adam executed 2 separate sales totaling 608,333 shares at a blended average price of $147.25, netting $89,577,563.33 and cutting his post-transaction holdings to 864,177 shares from 1,472,510 shares. The scale of this transaction—a 41.3% reduction in holdings—is material for a sitting CEO. At this ticker, his 5 prior sales show mixed timing outcomes (2 of 5 well-timed at the 90-day mark), and the most recent prior sale on 2025-04-25 saw the stock rise +37.9% over 90 days, suggesting earlier sells underestimated upside. Amphenol's fundamentals remain solid with $6.2B quarterly revenue, $1.2B net income, and +51.7% annual revenue growth, though the stock is -11.8% from its 52-week high at the current $146.72 price.

CEO NORWITT sells 2,000,000 shares (50% of holdings) for $151.5M at $75.73; stock up 15.2% in 30 days

NORWITT RICHARD ADAM, President & CEO, sold 2,000,000 shares (2.00M shares) of AMPHENOL CORP /DE/ on 2025-04-25 at $75.73, reducing his holdings from 4,002,507 shares to 2,002,507 shares—a 50.0% reduction in position size. The sale occurred as APH stock trades near its 52-week high ($78.55), currently at $76.68, and has gained 15.2% over the prior 30 days and 10.5% over 90 days. His cross-ticker track record shows 5 prior sells with an average 90-day return of -8.8% and a 60.00% well-timed rate, though at APH specifically, his prior 5 sales show mixed timing—3 of 5 were well-timed at the 90-day mark, with 2 most recent sells on 2024-10-29 each showing negative 90-day returns (-1.9% and -3.5%). The company fundamentals remain strong: revenue of $4,811,000,000.00 with annual growth of +21.2%, net income of $737,800,000.00, and a P/E of 35.50. The magnitude and timing of this CEO stake reduction—executed near multi-month highs—merit investor scrutiny of whether this signals any internal perspective shift or is a routine liquidity event.

Amphenol CEO Norwitt sold 1,190,000 shares for $82,204,730.60, reducing stake by 56.1% to 931.8K shares

Richard Adam Norwitt, President & CEO of Amphenol, executed 2 separate sales on 2024-10-29 totaling 1,190,000 shares (1.19M shares) for $82,204,730.60 at a blended average price of $69.08. This represents a 56.1% reduction in his post-transaction holdings from 2,121,836 shares to 931,836 shares. Norwitt's prior 3 open-market sells at Amphenol showed mixed timing outcomes: 2 of the 3 recent transactions in July 2024 generated positive 30-day and 90-day returns (+4.9%/+7.2% and +4.4%/+8.2%), while a July 2023 sell resulted in substantial declines (-50.6% 30-day, -54.1% 90-day), yielding a 33.33% well-timed rate across his cross-ticker track record. The company's current valuation shows a P/E of 36.82 with flat annual revenue growth (-0.5%), and the stock at $67.02 now sits 4.8% below its 52-week high of $70.41 after climbing 5.3% over the past 30 days.

CEO Richard Norwitt sells 400,000 shares (17.1% of holdings) at $64.28; stock down 11.8% from highs, P/E at 35.50.

Richard Adam Norwitt, President & CEO of Amphenol, executed a $25.7M sale of 400,000 shares at $64.28 on July 31, 2024, reducing his holdings from 2.33M to 1.93M shares. The sale occurs after the stock has declined 8.0% in the prior 30 days and 11.8% from its 52-week high of $70.41, with the company trading at a P/E of 35.50 on annual revenue growth of -0.5%. His cross-ticker track record shows 2 prior sells with an average 90-day return of -54.1% and a 90-day well-timed rate of 100%, and his prior sale at APH on July 28, 2023 was followed by a -54.1% 90-day return. This transaction, arriving just five days after another APH sale on July 26, occurs during a period of recent price weakness and follows a consistent pattern of the insider's prior exits preceding stock declines.

CEO Richard Norwitt sold 750,000 shares of APH at $64.54 for $48.4M, reducing stake by 27.9% to 1.93M shares.

Richard Norwitt, as President & CEO, executed a material reduction of his Amphenol stake, divesting 750,000 shares at $64.54 on 2024-07-26 and retaining 1,934,848 shares post-transaction. At the transaction price of $64.54, the stock was trading near the 52-week high of $70.41 (within ~8% of the peak), though it has since retreated to $61.94 (-12.0% from the 52-week high and -8.1% over 30 days). Within his cross-ticker trade history, Norwitt's prior sell at this same ticker (APH on 2023-07-28) showed -50.6% and -54.1% returns at the 30- and 90-day marks respectively, with a 100.00% well-timed rate on all prior sells, indicating a historical pattern of selling before declines. The company itself shows modest fundamentals: flat annual revenue growth (-0.5%), a high P/E of 35.39, and a $74.6B market cap, suggesting current valuations may already reflect elevated expectations. This large discretionary sale by the CEO warrants investor attention as both an indicator of conviction at that price point and as a data point in assessing whether management sees sufficient value at current levels to remain heavily invested.